Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Silencing of Tumor Necrosis Factor Receptor 1 by siRNA in EC109 Cells Affects Cell Proliferation and Apoptosis

View through CrossRef
Tumor necrosis factor receptor 1 (TNFR1) is a membrane receptor able to bind TNF‐α or TNF‐β. TNFR1 can suppress apoptosis by activating the NF‐κB or JNK/SAPK signal transduction pathway, or it can induce apoptosis through a series of caspase cascade reactions; the particular effect may depend on the cell line. In the present study, we first showed that TNFR1 is expressed at both the gene and protein levels in the esophageal carcinoma cell line EC109. Then, by applying a specific siRNA, we silenced the expression of TNFR1; this resulted in a significant time‐dependent promotion of cell proliferation and downregulation of the apoptotic rate. These results suggest that TNFR1 is strongly expressed in the EC109 cell line and that it may play an apoptosis‐mediating role, which may be suppressed by highly activated NF‐κB.
Title: Silencing of Tumor Necrosis Factor Receptor 1 by siRNA in EC109 Cells Affects Cell Proliferation and Apoptosis
Description:
Tumor necrosis factor receptor 1 (TNFR1) is a membrane receptor able to bind TNF‐α or TNF‐β.
TNFR1 can suppress apoptosis by activating the NF‐κB or JNK/SAPK signal transduction pathway, or it can induce apoptosis through a series of caspase cascade reactions; the particular effect may depend on the cell line.
In the present study, we first showed that TNFR1 is expressed at both the gene and protein levels in the esophageal carcinoma cell line EC109.
Then, by applying a specific siRNA, we silenced the expression of TNFR1; this resulted in a significant time‐dependent promotion of cell proliferation and downregulation of the apoptotic rate.
These results suggest that TNFR1 is strongly expressed in the EC109 cell line and that it may play an apoptosis‐mediating role, which may be suppressed by highly activated NF‐κB.

Related Results

MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Study in the Effect of EZH2 Gene Targeting siRNA on Cell Death in HL-60 Cell Line
Study in the Effect of EZH2 Gene Targeting siRNA on Cell Death in HL-60 Cell Line
Abstract Objective: To study small interfering RNA (siRNA) targeting EZH2 gene effect on cell proliferation, apoptosis and histone modulation in HL-60 cells line. ...
ERK5 knock down aggravates detrimental effects of hypothermal stimulation on cardiomyocytes via Bim upregulation
ERK5 knock down aggravates detrimental effects of hypothermal stimulation on cardiomyocytes via Bim upregulation
Objectives Our study was designed to investigate role of ERK5/Bim pathway in hypothermal stimulation-induced damage or apoptosis of cardiomyocytes. ...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
Abstract Introduction: Autophagy is a process whereby cells digest their own organelles in conditions of stress, such as low nutrient concentration, hypoxia or expos...
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
The diversity of autologous cells being used and investigated for cancer therapy continues to increase. Mast cells (MCs) are tissue cells that contain a unique set of anti-cancer m...
Abstract 4288: Targeted therapy against aldehyde dehydrogenase in ovarian cancer
Abstract 4288: Targeted therapy against aldehyde dehydrogenase in ovarian cancer
Abstract OBJECTIVE. Aldehyde dehydrogenase-1 (ALDH1) expression characterizes a subpopulation of cells with enhanced tumor initiating and differentiating properties ...
Overcoming the breast tumor microenvironment by targeting MDSCs through CAR-T cell therapy.
Overcoming the breast tumor microenvironment by targeting MDSCs through CAR-T cell therapy.
1032 Background: Successful targeting of solid tumors such as breast cancer (BC) using CAR T cells (CARTs) has proven challenging, largely due to the immune suppressive tumor micr...

Back to Top